Literature DB >> 30534862

[Mortality due to ischemic heart disease in Ecuador 2001- 2016. A time trend study].

Solange Núñez-González1, Sandy Aulestia-Ortiz1, Edison Borja-Villacrés1, Daniel Simancas-Racine1.   

Abstract

BACKGROUND: Ischemic Heart Disease (IHD) is the leading cause of mortality worldwide. AIM: To analyze the evolution of mortality by IHD in Ecuador, from 2001 to 2016.
MATERIAL AND METHODS: Analysis of Ecuador death registries elaborated by the National Statistics and Census Institute. Specific and age-adjusted mortality rates were calculated for the 2001-2016 period in Ecuador. The annual percent change (APC) and the average annual percent change (AAPC) were estimated. Changes in trends were located through joinpoint regression analysis.
RESULTS: From 2001 to 2016 there were 46,133 deaths due to IHD in Ecuador, of which 60% (n = 27,489) corresponded to men. In the joinpoint regression analysis, the crude mortality rates for IHD reported an increase in the AAPC of 4.0% (2001-2016, 95% CI: 1.5 - 6.6). Rates adjusted for age increased with an AAPC of 3.2% (2001-2016, 95% CI: 0.7 - 5.8).
CONCLUSIONS: Mortality due to ischemic heart disease increased in Ecuador in the period 2001-2016. Two marked periods were observed, one with a decrease followed by a significant increase, in both sexes and all age groups.

Entities:  

Mesh:

Year:  2018        PMID: 30534862     DOI: 10.4067/s0034-98872018000800850

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  2 in total

1.  Trends in Mortality from Ischemic Heart Disease in Peru, 2005 to 2017.

Authors:  Jesús Austin Vázquez-Troche; Vanessa García-Fernández; Akram Hernández-Vásquez; Rodrigo Vargas-Fernández; Guido Bendezu-Quispe
Journal:  Int J Environ Res Public Health       Date:  2022-06-09       Impact factor: 4.614

2.  Prevalence and Correlates of Self-Reported Cardiovascular Diseases Among a Nationally Representative Population-Based Sample of Adults in Ecuador in 2018.

Authors:  Supa Pengpid; Karl Peltzer
Journal:  Vasc Health Risk Manag       Date:  2021-05-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.